You just read:

Asterias Announces Additional Motor Function Improvement at 6-months and 9-months Following Treatment with AST-OPC1 in Patients with Complete Cervical Spinal Cord Injuries

News provided by

Asterias Biotherapeutics, Inc.

Jan 24, 2017, 07:00 ET